Page 2 - AMD AN OVERVIEW OF CLINICAL FORMS_Neat
P. 2

Contents









                  1     Age-related macular degeneration: epidemiology,

                      environmental and genetic risk factors...................................................................................................................13
                      Alexandra Mouallem-Bézière, Jean-Louis Bacquet




                  2     Multimodal imaging for age-related macular

                      degeneration  ..............................................................................................................................................................................................................................................21

                      Part 1: Non-invasive imaging .................................................................................................................................................................22
                      Setha Vo Kim, Francesca Amoroso

                      Part 2: Optical coherence tomography angiography
                      (OCTA) ...............................................................................................................................................................................................................................................................................34
                      Alexandra Miere, Roxane Bunod, Eric Souied

                      Part 3: Invasive imaging...........................................................................................................................................................................................40
                      Setha Vo Kim, Francesca Amoroso





                  3     Age-related maculopathy  .................................................................................................................................................................................47
                      Mayer Srour




                  4     Type 1 neovascularization  ...............................................................................................................................................................................61
                      4.1   Type 1 - Jean-Louis Bacquet, Alexandra Mouallem-Bézière ......................................................................................................62
                      4.2   Quiescent - Vittorio Capuano .......................................................................................................................................................................................................................70
                      4.3   Retinal pigment epithelial tears - Alexandra Mouallem-Bézière ................................................................................78

                      4.4   Wrinkled pigment epithelial detachments - Gérard Mimoun ..........................................................................................82
                      4.5   Peculiar pre-epithelial type 2 neovascularization healing mode
                            following anti-VEGF treatment: “igloos” - Gérard Mimoun .................................................................................................90

                      4.6   Polypoidal choroidal vasculopathy (or aneurysmal type 1
                            choroidal neovascularization) - Mayer Srour, David Sayag ....................................................................................................96


                      4.7 Fibrous choroidal neovascularization ...............................................................................................................................................................................104
                           Alexandra Miere, Manar Addou-Regnard, Eric Souied






                  10 • AMD: AN OVERVIEW OF CLINICAL FORMS
   1   2   3   4   5   6   7